ARCT icon

Arcturus Therapeutics
ARCT

Overview Fund Activity

165 hedge funds and large institutions have $820M invested in Arcturus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+20
Holders Change %
+13.79%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
52
Reduced
55
Closed
14
Calls
$9.75M
Puts
$9.89M
Net Calls
-$142K
Net Calls Change
+$792K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$36.7M
2
SSA
2
Schonfeld Strategic Advisors
New York
$12.7M
3
BlackRock
3
BlackRock
New York
$75.6M
4
GLA
4
Great Lakes Advisors
Illinois
$6.53M
5
JAM
5
Jupiter Asset Management
United Kingdom
$11.4M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$554K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$322K
3
Citadel Advisors
3
Citadel Advisors
Florida
$11.6K
4
PCM
4
Portolan Capital Management
Massachusetts
$4.6M
5
Invesco
5
Invesco
Georgia
$418K
Name Holding Trade Value Shares
Change 		Shares
Change %
VA
176
Vident Advisory
Georgia
– -$205K -8,039 Closed
SWM
177
Spire Wealth Management
Virginia
– -$7.92K -310 Closed
Bessemer Group
178
Bessemer Group
New Jersey
– -$8K -300 Closed
National Bank of Canada
179
National Bank of Canada
Quebec, Canada
– -$1.8K -70 Closed
Russell Investments Group
180
Russell Investments Group
United Kingdom
– -$613 -24 Closed
4 5 6 7
8